The Antiphospholipid syndrome (APS), formerly known as Anticardiolipin or Hughes
syndrome, is a systemic autoimmune disorder characterized by obstetrical complications …

Abstract Purpose of the Review To review the available evidence on the management of a
variety of non-criteria manifestations in antiphospholipid syndrome (APS), including valvular …

Novel insights into pathogenesis, diagnosis and treatment of... : Current Opinion in
Rheumatology Novel insights into pathogenesis, diagnosis and treatment of …

Objectives Extra-criteria manifestations of antiphospholipid syndrome (APS) might impact on
prognosis and morbidity of the disease. In this study, we aimed to evaluate a population of …

An update on inflammation in antiphospholipid syndrome : Current Opinion in Rheumatology An
update on inflammation in antiphospholipid syndrome : Current Opinion in Rheumatology Log in …

Update on the pathogenesis and treatment of the antiphosphol... : Current Opinion in
Rheumatology Update on the pathogenesis and treatment of the antiphospholipid syndrome …

Abstract Purpose of Review Laboratory criteria for the classification of antiphospholipid
syndrome include the detection of a lupus anticoagulant and/or anticardiolipin and anti-β2 …

Antiphospholipid syndrome: an update for clinicians and scie... : Current Opinion in
Rheumatology Antiphospholipid syndrome: an update for clinicians and scientists : Current …

Recurrent thrombosis is the hallmark of the antiphospholipid syndrome (APS). Pregnancy
losses and cytopenias (thrombocytopenia or hemolytic anemia) may occur as the sole …

Background From this retrospective study, we aimed to (1) describe the prevalence and
characteristics of non-criteria features in primary antiphospholipid syndrome (p-APS) and (2) …